TABLE 2.
N = 459 | |
---|---|
Prior surgery, n (%) | 342 (76.5) |
Missing | 12 |
Prior radiation therapy, n (%) | 370 (81.7) |
Missing | 6 |
Number of metastatic treatment lines, n (%) | |
2 | 97 (21.1) |
3 | 90 (19.6) |
4 | 65 (14.2) |
5 | 67 (14.6) |
≥ 6 | 140 (30.5) |
Median (range) | 4 (2–22) |
Prior treatment for metastatic disease, n (%) | |
Trastuzumab | 458 (99.8) |
Trastuzumab emtansine | 435 (94.8) |
Pertuzumab | 364 (79.3) |